"$70 million" windfall recovered from Biogen Idec dwarfs Vernalis' market cap
12 April 2011
Sukaina Virji
Please Login to read the full article.
12 April 2011
Sukaina Virji
Please Login to read the full article.
RELATED CONTENT
NEWS
- Stockwatch: Premature evaluation
- Australia's Biota merges with Nabi for cash and exposure to larger US investment market
- Amylin and Bristol-Myers Squibb deny reports that Amylin rejected $3.5 billion offer
- Pharma CEO compensation declines, but still no correlation with performance
ANALYSIS
Other Informa Analysis
COMMENT
Other Informa Comment
FEATURES
- Chinese producers may be losing price edge to India, says Granules MD
- Merck BioVentures: where biosimilars make a difference
EVENTS
Today
Continental Zara Hotel, Budapest, Hungary
Today
Radisson Blu Royal Hotel, Dublin
Today
Hotel Sofitel Hamburg Alter Wall
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
